[HTML][HTML] Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the …
…, B Azmi, R Giddings, M Shrotri, N Kaur… - The Lancet Healthy …, 2022 - thelancet.com
Background Long-term care facilities (LTCFs) have reported high SARS-CoV-2 infection
rates and related mortality, but the proportion of infected people among those who have …
rates and related mortality, but the proportion of infected people among those who have …
[HTML][HTML] Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care …
…, M Krutikov, P Sylla, D Bone, N Kaur… - The Lancet Healthy …, 2021 - thelancet.com
Background Residents of long-term care facilities (LTCFs) have been prioritised for COVID-19
vaccination because of the high COVID-19 mortality in this population. Several countries …
vaccination because of the high COVID-19 mortality in this population. Several countries …
[HTML][HTML] Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4+ T cell recognition
CD4 + T cells are essential for protection against viruses, including SARS-CoV-2. The
sensitivity of CD4 + T cells to mutations in SARS-CoV-2 variants of concern (VOCs) is poorly …
sensitivity of CD4 + T cells to mutations in SARS-CoV-2 variants of concern (VOCs) is poorly …
[HTML][HTML] Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational …
…, T Lancaster, P Sylla, MS Butler, N Kaur… - The Lancet Healthy …, 2022 - thelancet.com
Background Older age and frailty are risk factors for poor clinical outcomes following SARS-CoV-2
infection. As such, COVID-19 vaccination has been prioritised for individuals with …
infection. As such, COVID-19 vaccination has been prioritised for individuals with …
[HTML][HTML] Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes
…, C Bentley, U Amin, A Jadir, S Hulme, N Kaur… - Nature Aging, 2023 - nature.com
Third-dose coronavirus disease 2019 vaccines are being deployed widely but their efficacy
has not been assessed adequately in vulnerable older people who exhibit suboptimal …
has not been assessed adequately in vulnerable older people who exhibit suboptimal …
Severe acute respiratory syndrome coronavirus 2 anti-spike antibody levels following second dose of ChAdOx1 nCov-19 or BNT162b2 vaccine in residents of long …
…, B Azmi, T Lancaster, P Sylla, N Kaur… - The Journal of …, 2022 - academic.oup.com
General population studies have shown strong humoral response following severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination with subsequent waning of anti-…
respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination with subsequent waning of anti-…
[HTML][HTML] Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-naïve residents of long-term care facilities who survive natural infection
…, MS Butler, P Sylla, E Spalkova, D Bone, N Kaur… - Nature Aging, 2022 - nature.com
We studied humoral and cellular immunity against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) in 152 long-term care facility staff and 124 residents over a …
coronavirus 2 (SARS-CoV-2) in 152 long-term care facility staff and 124 residents over a …
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibody in staff and residents of long-term care facilities over the first year of the pandemic …
Background Long Term Care Facilities (LTCF) have reported high SARS-CoV-2 infection
rates and related mortality, but the proportion infected amongst survivors and duration of the …
rates and related mortality, but the proportion infected amongst survivors and duration of the …
Booster vaccination strongly enhances SARS-CoV-2-specific antibody and cellular responses in elderly residents of care homes
…, C Bentley, U Amin, A Jadir, S Hulme, N Kaur… - 2021 - papers.ssrn.com
Third dose ‘booster’COVID-19 vaccines can increase SARS-CoV-2 specific immune
responses and are being deployed widely to control the impact of omicron variant infection. …
responses and are being deployed widely to control the impact of omicron variant infection. …
Some results on vanishing coefficients in infinite product expansions
Recently, Hirschhorn proved that, if $$\begin{aligned} \sum _{n=0}^{\infty }a_nq^n&:=(-\,q,-\,q^4;q^5)_\infty
(q,q^9;q^{10})_\infty ^3 \end{aligned}$$ ∑ n = 0 ∞ a n q n : = ( - q , - q 4 ; q 5 ) …
(q,q^9;q^{10})_\infty ^3 \end{aligned}$$ ∑ n = 0 ∞ a n q n : = ( - q , - q 4 ; q 5 ) …
